首页> 外文会议>Biochemical Society Annual Symposium >Crystallizing membrane proteins for structure-function studies using iipidic mesophases
【24h】

Crystallizing membrane proteins for structure-function studies using iipidic mesophases

机译:使用IIPIDIC中间蛋白酶结晶膜蛋白,用于结构功能研究

获取原文

摘要

The Iipidic cubic phase method for crystallizing membrane proteins has posted some high-profile successes recently. This is especially true in the area of G-protein-coupled receptors, with six new crystallographic structures emerging in the last 31/2 years. Slowly, it is becoming an accepted method with a proven record and convincing generality. However, it is not a method that is used in every membrane structural biology laboratory and that is unfortunate. The reluctance in adopting it is attributable, in part, to the anticipated difficulties associated with handling the sticky viscous cubic mesophase in which crystals grow. Harvesting and collecting diffraction data with the mesophase-grown crystals is also viewed with some trepidation. It is acknowledged that there are challenges associated with the method. However, over the years, we have worked to make the method user-friendly. To this end, tools for handling the mesophase in the pico- to nano-litre volume range have been developed for efficient crystallization screening in manual and robotic modes. Glass crystallization plates have been built that provide unparalleled optical quality and sensitivity to nascent crystals. Lipid and precipitant screens have been implemented for a more rational approach to crystallogenesis, such that the method can now be applied to a wide variety of membrane protein types and sizes. In the present article, these assorted advances are outlined, along with a summary of the membrane proteins that have yielded to the method. The challenges that must be overcome to develop the method further are described.
机译:结晶膜蛋白的IIPIDIC立方相法在最近发布了一些高型成功。在G蛋白偶联的受体面积中尤其如此,在过去31/2岁中出现了六种新的晶体结构。慢慢地,它正在成为具有经过验证的记录和令人信服的一般性的被接受的方法。然而,它不是在每个膜结构生物学实验室中使用的方法,这是不幸的。在采用它的不情愿部分部分地是与处理晶体生长的粘性粘性立方中间相的预期困难。还观察了利用中间相生长的晶体收获和收集衍射数据。承认,与该方法有关的挑战。然而,多年来,我们已经努力使方法友好。为此,已经开发出用于在手动和机器人模式下进行高效结晶筛选的用于处理中间相的工具。已经建造了玻璃结晶板,为新的晶体提供无与伦比的光学质量和敏感性。已经实施了脂质和沉淀剂筛网,用于更合理的结晶方法,使得该方法现在可以应用于各种膜蛋白类型和尺寸。在本文中,概述了这些各种进展,以及已经产生的膜蛋白质的概述。描述了必须克服以进一步克服的挑战进一步。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号